Tenon Medical price to sales ratio TNON
Market value divided by revenue over the last twelve months, since 2023.
- Today, Nov 2, 2026
- 0.2×
- 4-year median
- 1.7×
- Against its 4-year history
- 0th
- percentile: 0 is its lowest day, 100 its highest
- 4-year range
- 0.2× to 34.8×
- Peer median
- 0.3×
Tenon Medical's price to sales ratio is 0.2× as of Nov 2, 2026.
That is below its 4-year median of 1.7×, lower than on 100% of days in the last 4 years.
Over that time it ranged from 0.2× in Nov 2026 to 34.8× in Mar 2023.
The median for 10 medical instruments and supplies stocks of a similar size is 0.3×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 0.2× | 0.2× | 2.6× |
| 2025 | 2.8× | 0.9× | 4.5× |
| 2024 | 1.7× | 0.5× | 2.6× |
| 2023 | 1.6× | 0.9× | 34.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Tenon Medical's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| TNONTenon Medical | 0.2× |
| BBLGBone Biologics | n/m |
| IVFINVO Fertility | 0.2× |
| AMIXAutonomix Medical | n/m |
| NXGLNexgel | n/m |
| ADGMAdagio Medical | n/a |
| VJETFlyte Aviation | 0.4× |
| XAIRBeyond Air | 0.3× |
| VVOSVivos Therapeutics | 0.1× |
| CODXCo-Diagnostics | 3.1× |
| BJDXBluejay Diagnostics | n/m |
| Peer median | 0.3× |
Where Tenon Medical ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Tenon Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.